L’échoendoscopie peut-elle influencer la prise en charge et l’évolution du cancer pancréatique?
Tóm tắt
La prise en charge du cancer pancréatique concerne surtout les patients présentant une tumeur potentiellement résécable. Les informations fournies par l’échoendoscopie permettent une approche thérapeutique multidisciplinaire en fonction de la stadification TNM. Cependant cette approche sélective ne peut modifier l’évolution clinique que si les traitements proposés sont efficaces. Une approche thérapeutique multidisciplinaire dépendant du stade d’envahissement devrait permettre d’améliorer le pronostic des patients présentant un cancer pancréatique. Puisque l’USE est devenue la technique la plus fiable pour l’évaluation du cancer pancréatique, l’utilisation de la classification TNM basée sur l’USE devrait permettre des nouveaux progrès grâce à l’application de traitements mieux sélectionnés.
Tài liệu tham khảo
SNADY H. — The role of endoscopic ultrasonography in diagnosis, staging, and outcomes of gastrointestinal diseases.The Gastroenterologist. 1994,2, 91- 110.
SNADY H., COOPERMAN A., SIEGEL J. — Endoscopic ultrasonography compared with computed tomography with ERCP in patients with obstructive jaundice or small peripancreatic mass.Gastrointest. Endosc., 1992,38, 27–34.
SNADY H. — Clinical utility of endoscopic ultrasonography for pancreatic tumors.Endoscopy, 1993,16, 182–184.
MURR M., SARR M., OISHI A., VAN HEERDEN J. — Pancreatic cancer.CA Cancer J. Clin., 1994,44, 304–318.
BALEN F., LITTLE A., SMITH A., THEIS B., ABRAMS K., HOUGHTON J., HATFIELD A., RUSSEL R., LEES W. — Biopsy of inoperable pancreatic tumors does not adversely influence patient survival time.Radiology, 1994,193, 753–5.
WADE T., RADIORD D., VIRGO K., JOHNSON F. — Complications and outcomes in the treatment of pancreatic adenocarcinoma in the United States veteran.J. Am. Coll. Surg., 1994,179, 38–48.
HERTER F. P., COOPERMAN A.M., AHLBORN T.N., ANTINORI C. — Surgical experience with pancreatic and periampullary cancer.Ann. Surg., 1982,195, 3: 274–281.
SIEGEL J.H., SNADY H. — The significance of endoscopically placed prostheses in the management of biliary obstruction due to carcinoma of the pancreas: Results of non-operative decompression in 227 patients.Am. J. Gastroenterol., 1986,81, 634–41
WARSHAW A.L., FERNANDEZ-DEL CASTILLO C. — Medical progress — pancreatic carcinoma.N. Engl. J. Med., 1992,326, 455–465.
COOPERMAN A. — When is surgery indicated as the inital-treatment for pancreatic neoplasm? In: SNADY H., LAMBROZA A. Clinical endoscopy: practice and opinions. New York Society for Gastrointestinal Endoscopy — postgraduate course. 1994, p. 37.
BRUCKNER H., KALNICKI S., DALTON J., SNADY H., SCHWARTZ G., CHESSER M., LEHRER D., MANDELI J., HARPAZ N., JANUS C. — Survival after combined modality therapy for pancreatic cancer.J. Clin. Gastroenterol., 1993,16, 199–203.
MANABE T., TOBE T. — Progress in the diagnosis and treatment of pancreatic cancer — the Kyoto University experience.Hepatogasroenterology, 1989,36, 431–436.
RATTNER D. W. — Pancreatic cancer in 1992: Has any progress been noted?Mayo. Clin. Proc., 1992,67, 907–909.
WATANAPA P., WILLIAMSON R.C.N. — Surgical palliation for pancreatic cancer: developments during the past two decades.Brit. J. Surg., 1992,79, 8–20.
SNADY H. — Endoscopic ultrasonography: an effective new tool for diagnosing gastrointestinal tumors.Oncology, 1992,6, 63–74.
NEFF R. — What are the roles of CT, MRI, EUS, endoscopy and angiography in staging pancreatic neoplasm? In: SNADY H., LAMBROZA A. Clinical endoscopy: practice and opinions. New York Society for Gastrointestinal Endoscopy — postgraduate course. 1994, p 37.
ROSCH T., LORENZ R., BRIAG C., FEUERBACH S., SIEWERT J.R., SCHUSDZIARRA V., CLASSEN M. — Endoscopic ultrasound in pancreatic tumor diagnosis.Gastrointest. Endosc., 1991,37, 347–352.
YASUDA K., MUKAI H., FUJIMOTO S., NAKAJIMA M., KAWAI K. — The diagnosis of pancreatic cancer by endoscopic ultrasonography.Gastrointest. Endosc., 1988,34, 1–8.
CALETTI G., ODEGARD S., ROSCK T., SIVAK M.V., TIO T.L., YASUDA K. — Endoscopic ultrasonography (EUS): a summary of the conclusion of the working party for the Tenth World Congress of Gastroenterology Los Angeles, California October, 1994.Am. J. Gasroenterol., 1994,89, S138-S143.
WATANAPA P., WILLIAMSON R.C.N. — Surgical palliation for pancreatic cancer: Developments during the past two decades.Brit. J. Surg. 1992,79, 8–20
YEO C.J., CAMERON J.L., LILLEMOE K.D., SITMANN J.V., HRUBAN R.H., GOODMAN S.N., DOOLEY W.C., COLEMAN J., PITT H.A. Pancreaticoduodenectomy for cancer of the head of the pancreas.Ann. Surg., 1995,221, 721–733.
SNADY H., BRUCKNER H., SIEGEL J., COOPERMAN A., CHESSER M., KIEFER L. — Influence of combined chemotherapy, radiotherapy and surgery on survival of patients-with unresectable pancreatic carcinoma using computed tomography and endoscopic ultrasound to select treatment.Gastroenterol., 1994,106, A28.
WEESE J., NUSSBAUM M., PAUL A., ENGSTROM P., SOLIN L., KOVWALYSHYN M. — Increased resectability of locally advanced pancreatic and periampullary carcinoma with neoadjuvant chemoradiotherapy.Int. J. Pancreatol., 1990,7, 177–85.
YEUNG R., WEESE J., HOFFMAN J., SOLIN L., PAUL A., ENGSTROM P., LITWIN S. — Neoadjuvant chemoradiotherapy in pancreatic and duodenal carcinoma. A phase II Study.Cancer, 1993,72, 2124–33
HOFFMANN J.P., WOESE J.L., SOLIN L.J., ENGSTROM P., LITWIN S., LISENBERG B.I. — A pilot study of preoperative chemoradiation for patients with advanced, localized adenocarcinoma of the pancreas.Gastroenterol., 1994, 106, p. 74.
EVANS D., RICH T., BYRD D., CLEARY K., CONNELLY J., LEVIN B. — Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.Arch. Surg., 1992,127, 1335–9.
MERRICK W., DOBELBOWER R. — Aggressive therapy for cancer of the pancreas. Does it help?Gasroenterol. Clin. N. Am., 1990,19, 935–62.
DOUGLASS H. — Current approaches to multimodality management of advanced pancreatic cancer.Hepatogastroenterology, 1993,40, 433–42.